The Society of Interventional Radiology (SIR) published new practice guidance for the use of prostatic artery embolization (PAE) to treat an enlarged prostate or benign prostatic hyperplasia (BPH). The guidance was published online in the Journal of Vascular and Interventional Radiology (JVIR).
This update to SIR’s 2019 Multi-society Consensus Position Statement on PAE captures new evidence supporting PAE as an effective alternative to conventional surgical treatments such as transurethral resection of the prostate (TURP). It also reflects the procedure’s acceptance by the American Urologic Association as a viable treatment option for managing BPH-related lower urinary tract symptoms (LUTS).
This document provides evidence-based guidance for healthcare providers on the clinical evaluation of BPH patients, appropriate diagnostic and pre-procedural imaging, and appropriate treatments tailored to the diagnosis.
“Prostatic artery embolization offers men a minimally invasive, effective treatment option for enlarged prostate that can significantly improve urinary symptoms while reducing the risks and recovery time associated with traditional surgery,” said SIR president Saher S Sabri, interventional radiologist at MedStar Georgetown University Hospital in Washington, USA. “This guidance outlines a team-based approach to care that will help ensure patients have access to this durable, minimally invasive treatment.”
The document was developed by an SIR-appointed writing group of interventional radiologists and researchers specialising in PAE in collaboration with the SIR Guidelines and Statements Division.
